Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Dr. Jia Liu | Team Building and Team Management| Best Researcher Award

Capital Center for Children’s Health, Capital Medical University, China

Author Profile

Orcid

🌱 Early Academic Pursuits

Jia Liu began her academic journey with a strong focus on medical sciences, where she pursued an M.D. in Otolaryngology Head and Neck Surgery from Beijing Anzhen Hospital, affiliated with Capital Medical University, between 2013 and 2016. Her dedication to expanding her medical expertise led her to the University of Chicago, USA, in 2015, where she gained invaluable experience as a visiting student. This international exposure enriched her understanding of advanced clinical practices and set the stage for her future career.

💼 Professional Endeavors

After completing her academic training, Jia Liu began her professional career as a resident at Beijing Anzhen Hospital from 2016 to 2019. Here, she honed her clinical skills in otolaryngology, particularly in the diagnosis and treatment of head and neck disorders. Her dedication and growing expertise earned her a position as an attending physician at the Capital Center for Children’s Health, Capital Medical University, in 2019. In this role, she has continued to provide high-quality care while also actively engaging in research, making significant contributions to pediatric otolaryngology.

🔬 Contributions and Research Focus

Jia Liu’s research is distinguished by its focus on otolaryngology, with a particular emphasis on olfactory disorders. Her notable project, funded by the Beijing Natural Science Foundation from 2019 to 2020, focused on the “Pedigree study on the molecular mapping, screening, and expression of olfactory genes for isolated congenital anosmia.” This research has advanced the understanding of the genetic basis of olfactory disorders, paving the way for improved diagnostic methods and therapeutic strategies.

🏆 Accolades and Recognition

Jia Liu’s dedication and achievements have been recognized through several prestigious awards. In 2014, she received the “Merck Clinical Scholar Award” from the American Academy of Otolaryngic Allergy (AAOA), a recognition of her early potential in the field. The following year, she was awarded a Chinese Government Scholarship from the China Scholarship Council, enabling her to study abroad at the University of Chicago. Her exceptional contributions to medical science were further acknowledged with the Beijing Medical Science and Technology Prize in 2018 and the Chinese Medical Science and Technology Prize in 2019.

🌐 Impact and Influence

Jia Liu has significantly impacted the field of otolaryngology, especially in pediatric care. Her clinical expertise and commitment to research have established her as a respected figure in her field. Her work in understanding and treating olfactory disorders has not only advanced scientific knowledge but has also improved clinical practices.

🌟 Legacy and Future Contributions

Jia Liu is poised to continue making significant contributions to otolaryngology. Her commitment to exploring the genetic basis of olfactory disorders positions her to lead future breakthroughs in the diagnosis and treatment of these conditions. As she continues her work at the Capital Center for Children’s Health, her legacy as a dedicated clinician and researcher is set to grow.

📝Notable Publications

Evaluation of brain and neurophysiologic function in isolated congenital anosmia

Author(s): Liu J, Gao X, Zhan X, Lu Y, Yao L, Yi X, Gu Q
Journal: American Journal of Otolaryngology
Year: 2025

 The effect of nasopharyngeal obstruction on the olfactory bulb volume and olfactory sulcus depth in children

Author(s): Yao L, Liu J, Xiaoli Yi, Gu Q
Journal: European Archives of Oto-Rhino-Laryngology
Year: 2024

 Analysis of clinical characteristics in the patient with olfactory disorders

Author(s): Liu J, Zhan X, Yao L, Xie H, Chang F
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Prognostic value of olfactory bulb volume in patients with post-viral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2022

Predictors of posttreatment olfactory improvement in patients with postviral olfactory dysfunction

Author(s): Guo Y, Yao L, Sun Z, Huang X, Liu J, Wei Y
Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery (Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Year: 2021

Mr. puya zhao | Team Building and Team Management | Excellence in Research

Mr. puya zhao | Team Building and Team Management | Excellence in Research

AsymBio, China

Author Profile

Scopus

🌱 Early Academic Pursuits

Puya Zhao embarked on his academic journey at Henan Agricultural University, where he earned his bachelor’s degree in 2008. His passion for biotechnology and life sciences led him to pursue dual master’s degrees at two prestigious institutions—the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, and Tianjin University of Science and Technology—from 2008 to 2011. These formative years provided him with a robust foundation in bioprocessing and industrial biotechnology.

🚀 Professional Endeavors

Puya Zhao’s career is marked by significant achievements in the biopharmaceutical industry. Since July 2022, he has served as the Downstream Process Development Director at Shanghai AsymBio, where he has overseen the successful completion of over 30 Investigational New Drug (IND) projects, including monoclonal antibody, bispecific antibody, nanobody, Fc-fusion proteins, and other recombinant proteins. His leadership extends to managing a purification team of 15-20 members, where he is responsible for strategic design, experimental execution, report drafting, and team management.

Before his tenure at Shanghai AsymBio, Puya Zhao held the position of Associate Director of the Biosafety Testing (Suzhou) Department at WuXi Biologics from 2020 to 2022. Here, he specialized in viral clearance studies, leading a team of 15-23 members and developing a comprehensive database for viral clearance, which has become an essential resource for downstream process development.

🔬 Contributions and Research Focus

Puya Zhao has made substantial contributions to biopharmaceutical process development. His work includes the development of purification processes for various biologics, the translation of key texts on biopharmaceutical manufacturing, and active participation in the ICH Q5A (R2) domestic expert working group. He has also led initiatives in process scale-up, technology transfer, and pilot plant management, ensuring compliance with Good Manufacturing Practice (GMP) standards.

His research is well-recognized in the scientific community, with notable publications in peer-reviewed journals. His recent SCI papers include studies on the application of an integrated full-membrane platform for antibody purification and a non-affinity platform for processing knob-into-hole bispecific antibodies, both published in Bioresources and Bioprocessing in 2024.

🏆 Accolades and Recognition

Puya Zhao’s expertise is further demonstrated by his role in the ICH Q5A (R2) domestic expert working group, where he has participated in the review and finalization of regulatory documents and maintained active communication with regulatory agencies. His innovative approach is reflected in his intellectual property portfolio, with six patents submitted, two of which have been officially filed.

🌐 Impact and Influence

Puya Zhao’s leadership in downstream process development has significantly impacted the biopharmaceutical industry, particularly in the purification and safety testing of biologics. His contributions to process optimization, viral clearance, and scale-up strategies have set benchmarks for best practices in the field. His expertise is not only recognized within his organization but also in the broader biopharmaceutical sector.

🌟 Legacy and Future Contributions

Looking forward, Puya Zhao is poised to continue his contributions to biopharmaceutical innovation. His commitment to research, process optimization, and regulatory excellence positions him as a key figure in the development of safe and effective biologics. As he continues to lead teams and drive scientific advancements, his impact on the industry is set to grow further.”)}

📝Notable Publications

Application of the Design of Experiment to Characterize Depth Filtration for Bispecific Antibody Clarification

Authors: Pan, Y., Li, M., Hong, H., Gao, K., Zhao, P.

Journal: Chemical Engineering Research and Design

Year: 2025